An oral-only, Phase 3 study of omadacycline for the treatment of acute bacterial skin and skin structure infections.
Phase of Trial: Phase III
Latest Information Update: 16 Jan 2017
At a glance
- Drugs Omadacycline (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Therapeutic Use
- 16 Jan 2017 New trial record